Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
NAPA Stock Summary
Top 10 Correlated ETFs
NAPA
In the News

The Duckhorn Portfolio, Inc. (NAPA) Q4 2023 Earnings Call Transcript
The Duckhorn Portfolio, Inc. (NYSE:NAPA ) Q4 2023 Earnings Conference Call September 27, 2023 4:30 PM ET Company Participants Sean Sullivan - Executive Vice President, Chief Strategy & Legal Officer Jennifer Fall Jung - Executive Vice President & Chief Financial Officer Conference Call Participants Christian Junquera - Bank of America Lauren Lieberman - Barclays Andrew Strelzik - BMO Capital Markets Andrea Teixeira - JPMorgan Operator Good afternoon and thank you for attending today's Duckhorn Portfolio Q4 and Full Year 2023 Earnings Conference Call. My name is Sierra [ph] and I'll be your moderator for today.

The Duckhorn Portfolio, Inc. (NAPA) Q4 Earnings Surpass Estimates
The Duckhorn Portfolio, Inc. (NAPA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.08 per share a year ago.

Duckhorn's stock rallies 9% after winemaker's profit tops views; CEO to retire
Shares of Duckhorn Portfolio Inc. NAPA turned lower in after hours Wednesday after the winemaker reported quarterly earnings that beat Wall Street expectations and said Chief Executive Alex Ryan was retiring after 35 years with the company. Duckhorn earned $17.8 million, or 15 cents a share, in the fiscal fourth quarter, compared with $5.4 million, or 5 cents a share, in the prior-year quarter.

5 Stocks With Rising P/E to Bet on for Solid Gains
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include Crocs (CROX), AlloVir (ALVR), Arcadia Biosciences (RKDA), The Duckhorn Portfolio (NAPA) and Genuine Parts (GPC).

Is the Options Market Predicting a Spike in The Duckhorn Portfolio (NAPA) Stock?
Investors need to pay close attention to The Duckhorn Portfolio (NAPA) stock based on the movements in the options market lately.

5 Top-Ranked Stocks With Rising P/E Worth Investing In
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Planet Fitness (PLNT), AlloVir (ALVR), Entergy (ETR), The Duckhorn Portfolio (NAPA) and Genuine Parts (GPC).

Brown-Forman's (BF.B) Brands & Strategies Provide Growth Impetus
Brown-Forman (BF.B) continues to benefit from its strong brand portfolio, premiumization efforts and aggressive brand investments.

Bet on DuPont Analysis to Pick 5 Stocks for Stellar Returns
Do you have more faith in DuPont analysis than simple ROE calculation? Tap PDD Holdings Inc. (PDD), OpGen (OPGN), AGCO (AGCO), A10 Networks (ATEN) and The Duckhorn Portfolio (NAPA).

How Much Upside is Left in The Duckhorn Portfolio, Inc. (NAPA)? Wall Street Analysts Think 40.28%
The consensus price target hints at a 40.3% upside potential for The Duckhorn Portfolio, Inc. (NAPA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

The Duckhorn Portfolio, Inc. (NAPA) Q3 2023 Earnings Call Transcript
The Duckhorn Portfolio, Inc. (NYSE:NAPA ) Q3 2023 Earnings Conference Call June 8, 2023 4:30 PM ET Company Participants Sean Sullivan - Chief Strategy & Legal Officer Alex Ryan - President & CEO Lori Beaudoin - CFO Conference Call Participants Lauren Lieberman - Barclays Peter Galbo - Bank of America Andrea Teixeira - JPMorgan Kevin Grundy - Jefferies Gerald Pascarelli - Wedbush Securities Robert Ottenstein - Evercore Operator Good morning, and thank you for attending today's Duckhorn Portfolio Q3 2023 Earnings Conference Call. My name is Jason.
NAPA Financial details
NAPA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-07-31
Metric | History | 2019-07-31 | 2020-07-31 | 2021-07-31 | 2022-07-31 |
---|---|---|---|---|---|
Revenue per share | 2.18 | 2.45 | 3.16 | 3.24 | |
Net income per share | 0.2 | 0.29 | 0.52 | 0.52 | |
Operating cash flow per share | 0.38 | 0.5 | 0.6 | 0.6 | |
Free cash flow per share | 0.22 | 0.38 | 0.47 | 0.21 | |
Cash per share | 0.03 | 0.06 | 0.04 | 0.03 | |
Book value per share | 5.61 | 5.91 | 7.51 | 7.53 | |
Tangible book value per share | -0.29 | 0.19 | 1.65 | 2.17 | |
Share holders equity per share | 5.61 | 5.91 | 7.51 | 7.53 | |
Interest debt per share | 3.95 | 3.59 | 2.45 | 2.2 | |
Market cap | 1.9B | 1.9B | 2.34B | 2.1B | |
Enterprise value | 2.31B | 2.27B | 2.59B | 2.35B | |
P/E ratio | 85.98 | 58.68 | 41.87 | 34.92 | |
Price to sales ratio | 7.88 | 7.02 | 6.96 | 5.64 | |
POCF ratio | 44.74 | 34.43 | 36.47 | 30.53 | |
PFCF ratio | 78.93 | 45.72 | 46.34 | 86.89 | |
P/B Ratio | 3.06 | 2.9 | 2.92 | 2.43 | |
PTB ratio | 3.06 | 2.9 | 2.92 | 2.43 | |
EV to sales | 9.59 | 8.4 | 7.68 | 6.3 | |
Enterprise value over EBITDA | 34.33 | 24.9 | 24.55 | 20.74 | |
EV to operating cash flow | 54.45 | 41.19 | 40.25 | 34.07 | |
EV to free cash flow | 96.05 | 54.69 | 51.14 | 96.96 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0.03 | |
Free cash flow yield | 0.01 | 0.02 | 0.02 | 0.01 | |
Debt to equity | 0.67 | 0.58 | 0.31 | 0.28 | |
Debt to assets | 0.36 | 0.33 | 0.21 | 0.2 | |
Net debt to EBITDA | 6.12 | 4.08 | 2.31 | 2.15 | |
Current ratio | 6.41 | 5.42 | 5.54 | 5.66 | |
Interest coverage | 2.02 | 3.53 | 6.17 | 12.88 | |
Income quality | 1.92 | 1.7 | 1.15 | 1.14 | |
Dividend Yield | 0 | 0 | 0.04 | 0 | |
Payout ratio | 0 | 0 | 1.79 | 0 | |
Sales general and administrative to revenue | 0.12 | 0.09 | 0.13 | 0.12 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.56 | 0.55 | 0.53 | 0.49 | |
Capex to operating cash flow | -0.43 | -0.25 | -0.21 | -0.65 | |
Capex to revenue | -0.08 | -0.05 | -0.04 | -0.12 | |
Capex to depreciation | -0.73 | -0.6 | -0.64 | -1.91 | |
Stock based compensation to revenue | 0 | 0 | 0.03 | 0.01 | |
Graham number | 5.02 | 6.24 | 9.42 | 9.41 | |
ROIC | 0.03 | 0.05 | 0.06 | 0.06 | |
Return on tangible assets | 0.04 | 0.06 | 0.1 | 0.09 | |
Graham Net | -3.64 | -3.21 | -2.04 | -1.83 | |
Working capital | 222.02M | 228.91M | 257.62M | 279.52M | |
Tangible asset value | -31.82M | 21.17M | 176.48M | 250.17M | |
Net current asset value | -277.41M | -223.27M | -66.48M | -44.83M | |
Invested capital | 0.67 | 0.58 | 0.31 | 0.28 | |
Average receivables | 0 | 24.47M | 29.86M | 35.14M | |
Average payables | 0 | 3.03M | 3.64M | 3.47M | |
Average inventory | 0 | 239.99M | 256.52M | 276.58M | |
Days sales outstanding | 34 | 35.69 | 36.06 | 36.28 | |
Days payables outstanding | 6.61 | 10.19 | 7.67 | 6.59 | |
Days of inventory on hand | 668.1 | 669.37 | 577.34 | 556.14 | |
Receivables turnover | 10.74 | 10.23 | 10.12 | 10.06 | |
Payables turnover | 55.21 | 35.83 | 47.6 | 55.39 | |
Inventory turnover | 0.55 | 0.55 | 0.63 | 0.66 | |
ROE | 0.04 | 0.05 | 0.07 | 0.07 | |
Capex per share | -0.17 | -0.12 | -0.13 | -0.39 |
Quarterly Fundamentals Overview
Last date of statement is 2023-04-30 for Q3
Metric | History | 2022-04-30 | 2022-07-31 | 2022-10-31 | 2023-01-31 | 2023-04-30 |
---|---|---|---|---|---|---|
Revenue per share | 0.8 | 0.68 | 0.94 | 0.9 | 0.79 | |
Net income per share | 0.14 | 0.05 | 0.17 | 0.13 | 0.15 | |
Operating cash flow per share | 0.25 | 0.18 | 0.23 | -0.07 | 0.29 | |
Free cash flow per share | 0.24 | 0.01 | 0.17 | -0.12 | 0.28 | |
Cash per share | 0.08 | 0.03 | 0.05 | 0.06 | 0.31 | |
Book value per share | 7.47 | 7.52 | 7.71 | 7.85 | 8 | |
Tangible book value per share | 2.09 | 2.17 | 2.37 | 2.53 | 2.7 | |
Share holders equity per share | 7.47 | 7.52 | 7.71 | 7.85 | 8 | |
Interest debt per share | 2.02 | 2.16 | 2 | 2.17 | 2.14 | |
Market cap | 2.24B | 2.1B | 1.68B | 1.86B | 1.76B | |
Enterprise value | 2.46B | 2.35B | 1.91B | 2.1B | 1.97B | |
P/E ratio | 35.91 | 97 | 21.25 | 31.24 | 26.25 | |
Price to sales ratio | 24.41 | 26.96 | 15.57 | 18.01 | 19.33 | |
POCF ratio | 77.02 | 100.26 | 63.83 | -224.91 | 52.4 | |
PFCF ratio | 81.12 | 1.74K | 84.34 | -130.73 | 55.22 | |
P/B Ratio | 2.6 | 2.43 | 1.9 | 2.06 | 1.91 | |
PTB ratio | 2.6 | 2.43 | 1.9 | 2.06 | 1.91 | |
EV to sales | 26.84 | 30.08 | 17.63 | 20.33 | 21.6 | |
Enterprise value over EBITDA | 87.28 | 206.21 | 54.78 | 92 | 59.67 | |
EV to operating cash flow | 84.67 | 111.87 | 72.29 | -253.83 | 58.56 | |
EV to free cash flow | 89.19 | 1.94K | 95.52 | -147.54 | 61.72 | |
Earnings yield | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0 | 0.01 | -0.01 | 0.02 | |
Debt to equity | 0.27 | 0.28 | 0.26 | 0.27 | 0.26 | |
Debt to assets | 0.19 | 0.2 | 0.17 | 0.19 | 0.18 | |
Net debt to EBITDA | 7.89 | 21.41 | 6.41 | 10.48 | 6.28 | |
Current ratio | 6.24 | 5.66 | 2.88 | 5.18 | 5.45 | |
Interest coverage | 12.88 | 2.76 | 13.4 | 5.71 | 8.86 | |
Income quality | 1.86 | 3.87 | 1.33 | -0.56 | 2 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.11 | 0.17 | 0.09 | 0.14 | 0.11 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.51 | 0.49 | 0.46 | 0.47 | 0.46 | |
Capex to operating cash flow | -0.05 | -0.94 | -0.24 | 0.72 | -0.05 | |
Capex to revenue | -0.02 | -0.25 | -0.06 | -0.06 | -0.02 | |
Capex to depreciation | -0.24 | -3.25 | -1.11 | -0.79 | -0.24 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | |
Graham number | 4.77 | 2.82 | 5.46 | 4.78 | 5.12 | |
ROIC | 0.01 | 0 | 0.02 | 0.01 | 0.02 | |
Return on tangible assets | 0.03 | 0.01 | 0.03 | 0.02 | 0.02 | |
Graham Net | -1.56 | -1.83 | -1.98 | -1.7 | -1.45 | |
Working capital | 292.94M | 279.52M | 281.18M | 319.4M | 340.97M | |
Tangible asset value | 240.18M | 250.17M | 273.05M | 291.84M | 311.63M | |
Net current asset value | -15.16M | -44.83M | -25.6M | -6.65M | 17.99M | |
Invested capital | 0.27 | 0.28 | 0.26 | 0.27 | 0.26 | |
Average receivables | 41.06M | 38.07M | 53.34M | 58.98M | 45.8M | |
Average payables | 7.45M | 4.21M | 24.64M | 32.15M | 10.66M | |
Average inventory | 294.8M | 288.75M | 313.68M | 334.48M | 327.17M | |
Days sales outstanding | 38.43 | 42.72 | 57.95 | 42.03 | 42.68 | |
Days payables outstanding | 9.53 | 7.87 | 77.25 | 34.3 | 6.44 | |
Days of inventory on hand | 551.99 | 664.17 | 575.62 | 609.34 | 723.24 | |
Receivables turnover | 2.34 | 2.11 | 1.55 | 2.14 | 2.11 | |
Payables turnover | 9.45 | 11.44 | 1.17 | 2.62 | 13.98 | |
Inventory turnover | 0.16 | 0.14 | 0.16 | 0.15 | 0.12 | |
ROE | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
Capex per share | -0.01 | -0.17 | -0.06 | -0.05 | -0.01 |
NAPA Frequently Asked Questions
What is The Duckhorn Portfolio, Inc. stock symbol ?
The Duckhorn Portfolio, Inc. is a US stock , located in Saint helena of Ca and trading under the symbol NAPA
Is The Duckhorn Portfolio, Inc. buy or a sell ?
3 stock analysts have 3 predictions with a medium analyst target price of $19.33. The lowest prediction is $14 and the highest is $23
What is NAPA stock prediction ?
With a median analyst target price of $14, 1 stock analysts have made 1 forecasts in last 90 days. $14 is the lowest and $14 is the greatest projection.
What is The Duckhorn Portfolio, Inc. stock quote today ?
The Duckhorn Portfolio, Inc. stock price is $10.3 today.
Is The Duckhorn Portfolio, Inc. stock public?
Yes, The Duckhorn Portfolio, Inc. is a publicly traded company.